Log In
BCIQ
Print this Print this
 

SB-030 (formerly SBCV-030)

  Manage Alerts
Collapse Summary General Information
Company Symic Bio Inc.
DescriptionMimic of the proteoglycan decorin, which binds to collagen that is exposed when the vascular endothelium is denuded
Molecular Target Collagen
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today